- Home
- IXHL vs FSP Comparison
IXHL vs FSP Comparison
Compare IXHL & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IXHL | FSP |
|---|---|---|
| Founded | 2001 | 1981 |
| Country | Australia | United States |
| Employees | 12 | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 33.3M |
| IPO Year | 2024 | 2001 |
Fundamental Metrics
Financial Performance| Metric | IXHL | FSP |
|---|---|---|
| Price | $2.77 | $0.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 54.6K | ★ 1.0M |
| Earning Date | 11-13-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | N/A | ★ 15.69 |
| EPS | N/A | ★ N/A |
| Revenue | $12,000.00 | ★ $107,162,000.00 |
| Revenue This Year | N/A | $16.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.30 |
| 52 Week High | $6.39 | $1.43 |
Technical Indicators
Market Signals| Indicator | IXHL | FSP |
|---|---|---|
| Relative Strength Index (RSI) | 30.81 | 54.60 |
| Support Level | $2.79 | $0.31 |
| Resistance Level | $3.89 | $0.40 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 6.65 | 73.49 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.